Yakira Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Yakira Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52,094	Closed	-$2.45M	–	227
2025 Q2	$2.45M	Buy	+52,094	New	+$2.32M	0.83%	39

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yakira Capital Management's SWTX Position: Q3 2025 in Review

Yakira Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 52,094 shares — an estimated $2.45M sold.

Yakira Capital Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $2.45M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Yakira Capital Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Yakira Capital Management sold 52,094 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.45M.
Yakira Capital Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Yakira Capital Management's SpringWorks Therapeutics position peaked at $2.45M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Yakira Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.